$ALB

Albemarle (ALB) Q2 2026 Earnings Call Transcript

Albemarle (ALB) discussed its Q2 2026 results and updated outlook on an earnings call. Q2 net sales were $1.7B, adjusted EBITDA $858M, and net income $480M, with EPS of $3.52. The company raised 2026 specialty outlook and expects energy storage volumes to be 225k to 235k tons LCE, citing a June 9 Greenbushes CGP3 fire and Middle East supply-chain impacts.

Original reporting
Published Aug 13, 2026, 2:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 2:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Albemarle (ALB) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$ALBBullishMed
01

Why it matters

Traders can reprice ALB based on raised specialties net sales and adjusted EBITDA ranges, while separately modeling energy storage sequential weakness due to CGP3 ramp delay and pricing lag effects on realized margins.

02

Market read

The call provides concrete guidance changes and segment-level margin drivers that can shift expectations for ALB’s 2026 earnings mix and near-term quarterly trajectory.

03

What to watch

The transcript notes Middle East-related cost/supply-chain uncertainty and a deferred-revenue cash-flow drag plus Kemerton Train 1 idling spend, which may matter more than EBITDA for near-term cash-focused positioning.

Relevance 8/10Novelty 7/10Timing: today’s earnings call guidance update for Q3 sequential and full-year 2026 ranges

Background

This is an earnings call transcript where Albemarle discusses Q2 2026 results, updates to 2026 outlook, and operational developments at Talison joint ventures (CGP3 fire restart, Wodgina performance) plus specialties bromine market disruptions.

Company-level read

Ticker impact

$ALBBullishMedium confidence
Context

Albemarle raised 2026 specialty sales and EBITDA outlook, citing strong YTD performance and reduced expected capital spending, while addressing CGP3 fire impacts.

Expected impact

Bias toward upside on the raised specialties outlook, partially offset by sequential Q3 declines tied to CGP3 ramp and pricing lag.

Evidence & confidence

The transcript includes specific Q2 results, raised full-year specialties ranges, and explicit energy storage volume and margin timing assumptions tied to CGP3 restart and spodumene inventory effects.

Market effects

Reinforces lithium and bromine-related pricing sensitivity and the importance of plant uptime and inventory timing for earnings season modeling in materials/energy storage supply chains.

Highlights Chile (Salar de Atacama, CGP3 restart) and Australia (Wodgina performance) operational factors that can swing quarterly output and realized pricing.

Middle East supply-chain disruption estimate ($70m-$90m unmitigated) is a cross-market risk input for commodity/materials traders.

Counterpoint

Energy storage guidance still implies sequential declines in Q3 and margin dilution risk from pricing and spodumene inventory timing, which could cap upside despite specialties strength.

Key entities

  • Albemarle

    ALB, reporting Q2 results and raising 2026 specialty outlook while updating energy storage volume and margin assumptions after CGP3 restart.

  • Talison joint venture

    Operational driver for energy storage volumes and margins, including CGP3 restart on Aug 1 and Wodgina outperforming on ore availability/recoveries.

  • Greenbushes CGP3 plant

    Fire on June 9; restarted Aug 1, affecting the timing of energy storage ramp and sequential Q3 performance.

Related articles

$ALBMed

Albemarle Q2 Earnings Call Highlights

Albemarle (ALB) said its CGP3 lithium plant restarted Aug. 1 and is ramping, with full run rate now expected in Q1 2027. Wodgina is running all three processing trains. The company expects Energy Storage sales and adjusted EBITDA to decline sequentially in Q3. Albemarle raised 2026 Specialties outlook to $1.4B-$1.6B net sales and $275M-$325M adjusted EBITDA, citing strong H1 results.

$ALBMedAI 8/10

ALB Q2 Earnings Call Highlights Storage Demand, Q3 Pressure

Albemarle (ALB) said on its Q2 2026 earnings call that tight lithium inventories and stronger stationary-storage demand support results. Adjusted EPS was $3.75 vs $3.35 expected, and revenue was $1.74B vs $1.59B. For Q3, Energy Storage sales, EBITDA and margins are expected to decline sequentially. 2026 lithium scenario targets were reaffirmed.

$ALBMed

Lithium Wrap: Albemarle Surges 5.5% on Price Outlook

Albemarle shares rose 5.54% to $125.42 after the company’s earnings call cited a more constructive lithium price outlook, faster EV battery restocking in China and South Korea, and reduced producer-held inventory. SQM gained 3.43% to $72.45. The Global X Lithium & Battery Tech ETF (LIT) fell 0.33% to $72.41.

$ALBMed

Albemarle Stock Jumps 8% as Lithium Pricing Triples EBITDA

Albemarle (NYSE:ALB) shares rose about 8% after Q2 results. The company reported revenue of $1.74B, up 31% year over year, with adjusted EBITDA up 155% to $858M and adjusted earnings of $3.75 per share. Energy Storage revenue increased 77.9% to $1.28B as realized lithium prices rose 60.5% to $19.53/kg. GuruFocus also cited ALB trading above its GF Value estimate.